Skip to content
Business

Québecor Makes a C$31bn Cash-and-Share Bid for Telus, Which Warns of Regulatory Risk

Québecor has offered C$6.35 in cash plus 0.17 of its own shares for each Telus share, a bid worth about C$31bn. The Telus board says the price falls short and the regulatory risk is high.

The Telus Garden office tower in downtown Vancouver, photographed in May 2025
Photo: Northwest / Wikimedia Commons, CC BY 4.0

Québecor, the Montreal owner of Vidéotron and Freedom Mobile, has made public an unsolicited bid for Telus worth about C$31bn, according to The Canadian Press: C$6.35 in cash plus 0.17 of a Québecor Class B share for every Telus share. On Monday 16 November the Telus board said the offer undervalues the company and carries significant regulatory risk, and Ottawa promised a rigorous review. Telus shares jumped almost 13% in Toronto, while Québecor's fell about 15%.

Québecor's offer for Telus

  • C$6.35 cash per Telus share, plus 0.17 of a Québecor Class B share
  • C$19.45 implied value per Telus share at Friday's prices, about 60% above Telus's close, Québecor says
  • 54% economic interest Telus holders would own in the combined company

Québecor put a 60% premium on the table

Québecor said it first sent Telus a non-binding proposal on 26 June and an enhanced one on 9 November. Valued at the close on Friday 13 November, the cash and shares came to about C$19.45 per Telus share, roughly 60% above Telus's closing price that day of C$12.14.

The pitch rests on cost, not growth. Québecor forecasts about C$160m a year in operating savings and C$235m a year in lower capital spending, on top of the C$900m annual efficiency programme Telus has already announced.

"Our transaction is not based on increasing revenues, it's certainly not based on increasing prices," chief executive Pierre Karl Péladeau told The Canadian Press.

Québecor's head office at 612 rue Saint-Jacques in Montreal.
Québecor's head office at 612 rue Saint-Jacques in Montreal. Photo: Jeangagnon / Wikimedia Commons, CC BY-SA 4.0
Telus in the three months to 16 November 2026. Daily closing prices from exchange data.
Telus in the three months to 16 November 2026. Daily closing prices from exchange data.

Telus says the risk lands on its shareholders

Telus replied at 7.30am Toronto time on Monday. A special committee of independent directors, chaired by board chair John Manley, is reviewing the proposal alongside other options. The board said it is not satisfied the offer reflects what Telus is worth, and that no decision has been made on whether to pursue a deal.

Its biggest worry is approval. More than four months after the first approach, the board said, Québecor had still not set out its regulatory strategy, or the remedies, meaning concessions such as asset sales, it would accept to win clearance. Manley warned that "a regulatory review of such a transaction would be a long and costly process for our shareholders."

The Telus board's other objections

  • Telus would contribute about 74% of the combined company's 2025 adjusted EBITDA, excluding Telus Health, yet its holders would be a voting minority and Québecor's controlling shareholder would name a majority of directors
  • Pro forma net debt would be about 4.1 times estimated 2027 EBITDA (earnings before interest, tax, depreciation and amortisation)
  • The November revision only lifted the share ratio from 0.1600 to 0.1700, worth about C$0.77 per Telus share or C$1.2bn in total, by Telus's count

Chief executive Victor Dodig told The Canadian Press that Telus has "serious concerns" and that the offer "doesn't nearly reflect the value of Telus".

What dividend investors would be swapping

Telus income investors were already hit this year. On 31 July Telus reset its quarterly dividend to C$0.1875 a share, or C$0.75 a year, from an annualised C$1.6736. The 55% cut is meant to free about C$2.7bn for debt reduction through 2028, the company said.

Québecor says it expects to keep its own annual dividend at C$1.80 a share. On the 0.17 of a share on offer, that comes to about C$0.31 a year for each Telus share given up. The Telus board says its shareholders "would receive a materially lower dividend".

For 100 Telus sharesTodayUnder Québecor's offer
Cash on completionNoneC$635
Shares held100 Telus17 Québecor Class B
Yearly dividend at current ratesC$75About C$30.60
Value at Monday's closeC$1,370About C$1,744

The fixed exchange ratio is a worry for the Telus board, because the share part moves with Québecor's stock. At Monday's close of C$65.25 the offer was worth about C$17.44 a Telus share, not C$19.45. Telus itself closed at C$13.70.

Ottawa and the regulators will have the final word

Québecor says the deal needs clearance from the Competition Bureau, from the CRTC, the broadcasting and telecoms regulator, and from the industry department for the transfer of spectrum licences.

The Competition Bureau said it was "aware of the announcements from Quebecor and Telus", according to Global News. Industry Minister Mélanie Joly said that "connectivity is critical to Canada's economy, sovereignty and national security, and to the daily lives of Canadians", and that the deal would be "rigorously reviewed".

Vidéotron bought Freedom Mobile in 2023 as part of Rogers' C$26bn takeover of Shaw, a sale Rogers and Shaw agreed to ease competition concerns. Telus has a market share of a little under 30% and Freedom just under 12%, lawyer Michael Osborne of Cozen O'Connor told Global News. Combined, he said, that would trip the competition threshold.

"Regulatory decisions will make or break the deal, not price," Scotiabank analyst Maher Yaghi wrote.

The two companies are due to meet next week

Telus has invited Québecor to meet on Monday 23 November. Even a friendly deal would need binding financing, both boards, and shareholder and court approval, Québecor says. Dodig pointed to Rogers' purchase of Shaw, which took more than two years to close.

Questions and answers

What is Québecor offering Telus shareholders?

Québecor has proposed C$6.35 in cash plus 0.17 of a Québecor Class B share for each Telus share. Québecor valued that at about C$19.45 a share at Friday 13 November prices.

Has Telus accepted the Québecor offer?

No. Telus's board said on Monday 16 November that the offer does not adequately reflect the company's value and carries significant regulatory risk. A special committee is reviewing it.

Would Telus shareholders get a lower dividend under the deal?

The Telus board says yes. Telus pays C$0.75 a year per share; 0.17 of a Québecor share would earn about C$0.31 at Québecor's C$1.80 annual dividend, before the C$6.35 of cash.

Sources

Related stories

Business

Tyson Foods Shares Jump 8.7% as Beef Outlook Outweighs a $74m Quarterly Loss

Tyson Foods posted a $74m fourth-quarter net loss and adjusted EPS of $0.61, down 47%, yet its shares closed 8.7% higher on Monday as its 2027 beef outlook pointed to far smaller…

Business

Siemens Energy More Than Triples Its Dividend and Plans Up to €9bn of Buybacks

Siemens Energy proposed a €2.30 dividend, up from €0.70, after a record year with €4.1 billion of net income and a €164 billion order backlog, and set up to €9 billion of buybacks…

Business

Red Cat Holdings Wins Steyr Motors Board Backing for Its €205m Takeover Offer

Steyr Motors' boards urged shareholders to accept Red Cat Holdings' €39-a-share cash offer, worth about €205m, for the Austrian engine maker. Acceptances close on 18 December.

Business

Deutsche Telekom Lifts Its Guidance and Plans a Record €1.10 Dividend

Deutsche Telekom beat third-quarter forecasts as adjusted EBITDA AL rose 8% organically to €12.2bn, lifted its 2026 goals on T-Mobile US strength and plans a 10% higher dividend of…

Business

Tyson Foods Shares Jump 8.7% as Beef Outlook Outweighs a $74m Quarterly Loss

Tyson Foods posted a $74m fourth-quarter net loss and adjusted EPS of $0.61, down 47%, yet its shares closed 8.7% higher on Monday as its 2027 beef outlook pointed to far smaller…

Business

Roche Wins FDA Approval for Breast Cancer Pill Wilserdly After 62% Cut in Progression Risk

The FDA approved Roche's all-pill Wilserdly combination for ESR1-mutated advanced breast cancer after it cut the risk of progression or death by 62%. A ruling on early-stage use is…

Business

ULA Loses Its First Mission as Vulcan Rocket Fails With 40 Amazon Leo Satellites on Board

United Launch Alliance's Vulcan rocket failed about 10 minutes after lift-off on Sunday, and all 40 Amazon Leo satellites were lost. Amazon fell 3.3% on Monday as space stocks…

Business

Tesla Plans €3bn Berlin Plant Expansion to Build Up to 1 Million Cybercabs a Year

Tesla plans to spend €3bn on a new hall at its Grünheide plant near Berlin that could build up to one million driverless Cybercabs a year, with production due to start in 2029.